SARS-COV-2 vaccination
2 papers3 findings
- 2 independent labs in 2 countries
- Funders: National Natural Science Foundation of China and 3 more
- Humans2
Associations
3High anti-SARS-CoV-2 antibody levels
upin humans1OR 4.36
1 study
High anti-SARS-CoV-2 antibody levels
upin humans1OR 4.36
SARS-COV-2 vaccination is associated with high anti-SARS-CoV-2 antibody levels in humans (OR 4.36).
“Receiving ≥ 3 vaccine doses was associated with high antibody levels (OR: 4.36, p = 0.001)”
Humansserum≥ 3 vaccine dosesn = 93
Journal of infection and public health10 Oct 2025
Neutralizing antibody production
upin humans1
1 study
Neutralizing antibody production
upin humans1
SARS-COV-2 vaccination is associated with neutralizing antibody production in humans.
“vaccination improved cTfh-cm, cTfh2, cTfr proportion and promoted NAb production.”
HumansCOVID-19
Clinical immunology (Orlando, Fla.)25 Jul 2024
cTfh-cm, cTfh2 and cTfr proportions
upin humans1
1 study
cTfh-cm, cTfh2 and cTfr proportions
upin humans1
SARS-COV-2 vaccination is associated with cTfh-cm, cTfh2 and cTfr proportions in humans.
“vaccination improved cTfh-cm, cTfh2, cTfr proportion and promoted NAb production.”
HumansCOVID-19
Clinical immunology (Orlando, Fla.)25 Jul 2024
Latest
Journal of Infection and Public Health
PhenoAge acceleration predicts antibody persistence and breakthrough infection after SARS-CoV-2 vaccination and infection
Cohort study of 93 peoplePhenoAge
Clinical Immunology
Age-dependent decrease of circulating T follicular helper cells correlates with disease severity in elderly patients with COVID-19
Cross-sectional study of 57 peopleMechanisms